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Abstract 
Background: Oral squamous cell carcinoma (OSCC) is the most common form of oral cancer, in this study, the asso-
ciation between OSCC and oral yeast carriage was investigated.
Findings: 20 patients having OSCC as well as 40 healthy controls were tested for the presence of yeasts in the oral 
cavity. Fungal burdens were examined by colony forming unit determinations, while the different yeast genera in 
patient samples were identified by matrix-associated laser desorption/ionization-time of flight-mass spectrometry. We 
found that the level of oral yeast carriage was significantly higher in patients with OSCC that was accompanied by a 
higher diversity of yeasts in the oral cavity of these patients. We also examined the extracellular enzyme production 
of isolated Candida spp.; however, we found that there was no association between the lipase/protease producing 
capacity of Candida strains and the higher colonisation rate of neoplastic epithelium.
Conclusions: In conclusion, our results corroborate the findings of previous studies regarding the association 
between oral yeast carriage and epithelial carcinoma.
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Background
Oral squamous cell carcinoma (OSCC) is the most com-
mon form of oral cancer, representing up to 80–90  % 
of all  malignancies of the oral cavity (Pires et  al. 2013). 
Among others, risk factors for OSCC include smoking, 
alcohol consumption, ultraviolet radiation and poor oral 
hygiene (Mohd et al. 2010). The occurrence of OSCC has 
also been associated with Candida infections, although 
the underlying pathogenic mechanisms are poorly under-
stood (Mohd et al. 2010).
Candida species belong to the normal flora and are fre-
quently isolated from various mucosal surfaces in healthy 
individuals (Sardi et al. 2013). However, they may cause 
cutaneous or systemic infections when the immunity 
of the host is compromised. Furthermore, although lit-
tle is known about the role of fungal infections in can-
cer, Candida spp. have long been implicated in various 
epithelial malignancies. There are several reports about 
chronic mucocutaneous candidiasis (CMC) patients 
developing oral or esophageal carcinoma (Mohd et  al. 
2010). Furthermore, chronic hyperplastic candidiasis 
(CHC, candidal leukoplakia), a rare form of oral candidi-
asis has been shown to often undergo malignant trans-
formation (Cawson 1966). A recent study has found that 
Candida species can be isolated with higher frequency 
from patients with oral epithelial dysplasia compared to 
healthy subjects (Hebbar and Pai 2013). Candida spp. 
have several attributes that may promote oral cancer 
development, such as the ability to produce carcinogens 
(e.g. nitrosamines), metabolize procarcinogens or induce 
inflammation (Mohd et al. 2010). However, the etiologi-
cal relationship between oral cancer and Candida infec-
tions is still a matter of debate and needs to be further 
investigated.
In this study, we assessed the presence of Candida 
spp. in the oral cavity of patients having keratinizing 
OSCC as well as healthy controls to investigate the asso-
ciation between Candida infections and oral cancer 
development.
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Methods
Patients
A total of 60 subjects [20 OSCC patients (14 males, 6 
females, median age: 62 (61.95), range 44–86) and 40 con-
trols (22 males, 18 females, median age: 67 (67.62), range 
49–82)] were enrolled in this study. The patients and the 
controls were recruited from among the patients of the 
Departments of Dentoalveolar Surgery and Maxillofa-
cial Surgery at the Faculties of Dentistry and Medicine at 
the University of Szeged. OSCC patients were eligible for 
this study if they had a histologically confirmed diagno-
sis and if they had not received any treatment for OSCC 
up to their participation. Controls were recruited from 
outpatients free of oral mucosal pathology who arrived 
for routine procedures (e.g. tooth extraction). The study 
design complied with the tenets of the Declaration of Hel-
sinki in all respects, and it was approved by the Research 
Ethics Committee for Human Medical Biology at the Uni-
versity of Szeged. The participation was voluntary and it 
was based on informed consent. Before their enrolment, 
all subjects received information about the background, 
aims and procedures of the study, and they had to sign an 
informed consent form to signify that they opted for par-
ticipation by their own free will and based on the infor-
mation they got. Frequency and locations of cancer sites 
in oral cancer patients: T1: carcinoma fundi oris l.d., T2: 
carcinoma linguae l.d., T3: carcinoma hypopharyngis l.s., 
T4: carcinoma radicis linguae l.d., T5. carcinoma gingi-
vae l.s., T6: carcinoma hypopharyngis l.s., T7: carcinoma 
linguae l.d, T8: carcinoma fundi oris l.s., T9: carcinoma 
fundi oris l.d., T10: carcinoma linguae l.s., T11: carcinoma 
radicis linguae l.s., T12: carcinoma linguae l.s., T13: car-
cinoma labii superioris vestibularis l.d., T14: carcinoma 
labii inferioris vestibularis l.s., T15: carcinoma mandibu-
lae ging. l.d., T16: carcinoma labii inferioris vestibularis 
l.d., T17: carcinoma fundi oris et gingivae l.s., T18: carci-
noma linguae l.d., T19: carcinoma fundi oris l.d., T20: car-
cinoma hypopharyngis l.d.
Oral samples
Oral swabs were taken from a 1 cm2 area from two dif-
ferent locations in the oral cavity (in the case of OSCC 
patients, both from the surface of neoplastic and healthy 
epithelium). Samples were inoculated on Sabouraud dex-
trose agar plates and Sabouraud broth, both incubated 
for 7  days at room atmosphere, in 32  °C. Direct sam-
ples that tested negative for yeast growth on agar plates 
after the first 3  days were subcultured from the liquid 
medium and incubated again for 7  days (referred to as 
“subculture”). Basic identification of the isolated yeasts 
was carried out based on macro- and micro-scopic mor-
phology, catalase test and CHROMagar Candida plates 
(Becton–Dickinson, UK), next MALDI-TOF (Bruker 
Daltonics, Bremen, Gr) analysis was carried out from all 
of the isolates.
MALDI‑TOF‑MS
Sample preparation was carried out according to the 
Bruker protocols using three methods: (1) direct trans-
fer (DT), (2) extended direct transfer (eDT), and (3) 
ethanol (EtOH)–formic acid (FA) extraction. In the DT 
method, a thin smear of biological material was placed 
onto a target plate, which was immediately overlaid with 
1  μl of alpha-cyano-4-hydroxycinnamic acid matrix 
solution (HCCA; Bruker Daltonics, Gr.), prepared 
according to the protocol of the manufacturer. In the 
eDT method, the biomass was treated with 1 μl of 70 % 
FA on the target plate prior to the HCCA matrix over-
lay. In the EtOH–FA method, one or two loops of yeast 
biomass (1 μl volume, sterile inoculation loop) was used 
for the crude protein extraction, as described previously 
(Lacroix et  al. 2014). One microliter of the crude pro-
tein extract was spotted onto the target plate, and after 
air-drying, it was overlaid with 1  μl of HCCA matrix 
solution. For all methods, each tested strain was spotted 
in duplicate. Standard commercially available Bruker 
Daltonics database (BDAL) was used in this study: indi-
vidual spectra using the MALDI Biotyper automated 
FlexControl software version 3.0 (Bruker Daltonics). 
The MALDI-TOF MS identification results were auto-
matically classified using the log-score values generated 
by the MALDI Biotyper software (Bruker Daltonics, 
Germany), performed according to the manufacturer’s 
instructions. Scores higher than 1.7 indicated genus-
level identification.
Analysis of lipase and protease activity
Extracellular lipase activity of Candida strains was exam-
ined on YNB-rhodamine B plates as previously described 
(Nemeth et al. 2013). Briefly, strains were inoculated onto 
YNB-rhodamine B (yeast nitrogen base) plates (Sigma-
Aldrich) and incubated at 30 °C for 7 days. Lipase positiv-
ity was determined by the presence of pink halo around 
the colonies. For the detection of proteolytic activity, 
Candida strains were cultured on YCB-BSA (yeast car-
bon base—bovine serum albumin, Sigma-Aldrich) agar 
plates at 30  °C for 7  days, and proteolysis around the 
colonies was visualised by amido black (Sigma-Aldrich) 
staining (Nemeth et al. 2013).
Statistical analysis
All statistical analyses have been performed by GraphPad 
Prism 5.0 software. Fisher’s exact test, Mann–Whitney 
test or Wilcoxon signed-rank test were used wherever 
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appropriate. Differences between groups were considered 
significant at p < 0.05.
Results
20 patients with confirmed OSCC as well as 40 healthy 
controls were enrolled in the study. 18 (90  %) of the 20 
OSCC patients and 12 (30  %) of the healthy controls 
had yeast isolated from their oral cavity (Table  1), indi-
cating that the frequency of oral yeast colonization was 
significantly higher in OSCC patients compared to the 
control group (Fisher’s exact test, p  <  0.0001). Further-
more, OSCC patients had a significantly higher aver-
age fungal burden (mean  ±  SEM, 73.08  ±  33.39  CFU/
cm2) in their oral cavity compared to healthy individu-
als (1.10  ±  0.78  CFU/cm2, Fig.  1a), and samples taken 
from the neoplastic surface contained more yeast cells 
(77.38 ±  38.53 CFU/cm2) compared to the swabs taken 
from the healthy epithelium of the same individual 
(28.58 ± 19.18 CFU/cm2, Fig. 1b). To assess the spectrum 
of yeast genera present in the oral cavity of healthy or 
OSCC patients, samples were subjected to peptide mass 
fingerprinting by matrix-associated laser desorption/
ionization-time of flight-mass spectrometry (MALDI-
TOF-MS). While the predominant fungal genus present 
in the oral cavity of both healthy and OSCC patients was 
Candida, we found that there was a higher diversity of 
yeasts in the oral swabs of cancer patients compared to 
healthy controls (Table 2). As the secretion of hydrolytic 
enzymes is an important virulence factor of Candida spp. 
(Nemeth et al. 2013; Stehr et al. 2004; Trofa et al. 2009; 
Monod and Borg-von 2002), we also examined whether 
the higher colonisation rate in the oral cavities of OSCC 
patients is associated with an increased prevalence of 
Candida strains with hydrolytic enzyme activity. To 
analyse the enzyme profiles of Candida strains, we have 
randomly chosen 40 isolates from healthy controls and 
140 isolates from OSCC patients and tested their extra-
cellular lipase and protease activity. However, we found 
that the enzyme production of isolates derived from the 
two different patient group did not differ significantly 
(Table 3).
Discussion
Candida infection has long been implicated in cancer 
development, particularly in malignancies affecting the 
oral epithelium (Mohd et al. 2010). In this study, we found 
that the level of oral yeast carriage is significantly higher 
in patients with OSCC. It has been previously shown 
that there is positive association between oral yeast car-
riage and epithelial carcinoma (Nagy et al. 1998; Barrett 
et al. 1998; McCullough et al. 2002; Jahanshahi and Shi-
rani 2015; Alnuaimi et al. 2015). Although the underlying 
mechanisms of how Candida species might promote car-
cinogenesis are still obscure, multiple mechanisms have 
been suggested to contribute to cancer development. 
These include the secretion of potential carcinogens, 
conversion of procarcinogens, damage of epithelial bar-
riers by secreted proteolytic enzymes as well as the ability 
to induce chronic inflammation (Mohd et al. 2010). In a 
mouse model of carcinogensis, C. albicans infection has 
Table 1 Prevalence of oral yeast carriage in OSCC patients 
and healthy controls
Oral yeast carriage Positive, N (%) Negative, N (%)
Control patients (n = 40)
 Original sample 3 (7.5) 37 (92.5)
 Subculture 12 (30) 28 (70)
OSCC patients (n = 20)
 Original sample 10 (50) 10 (50)
 Subculture 18 (90) 2 (10)
Fig. 1 Fungal burdens in the oral cavity of OSCC patients and healthy 
controls. a Average fungal burdens (mean ± SEM) in the oral cavity 
of control (n = 40) and OSCC patients (n = 20). In the case of OSCC 
patients, the average fungal burden of healthy and neoplastic epi-
thelial surface is shown. ***p < 0.001 (Mann–Whitney test). b Average 
fungal burdens on the healthy and neoplastic epithelial surface in 
the oral cavity of OSCC patients (n = 20). p value was determined by 
Wilcoxon signed-rank test
Table 2 Yeast genera identified in  OSCC and  control sam-
ples based on MALDI-TOF–MS analysis
Genus No. of isolates (%)
Control (N = 12) OSCC (N = 22)
Candida 10 (83.3) 15 (68.2)
Rhodotorula – 2 (9.1)
Saccharomyces – 2 (9.1)
Kloeckera – 1 (4.5)
Other yeast (unidentified) 2 (16.7) 2 (9.1)
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been shown to promote the development of 4 nitroqui-
noline 1-oxide (4NQO)-induced oral epithelial dysplasia, 
although the infection alone led only to the formation of 
hyperplastic lesions (Dwivedi et al. 2009). Here we tested 
a large number of yeast isolates from OSCC and control 
patients for extracellular enzyme production and found 
that there is no association between the lipase/protease 
producing capacity of strains and the higher colonisation 
rate of neoplastic epithelium. This finding questions the 
role of fungal hydrolytic enzymes in the development of 
epithelial dysplasia, although further experiments are 
needed to thoroughly examine their effect on carcino-
genesis. It has also been suggested that Candida infection 
is the consequence rather than the cause of malignant 
oral disorders, as the neoplastic epithelium represents 
an immunosuppressive microenvironment that may pro-
mote the survival of Candida spp. It has been recognized 
during the recent years that there is a delicate interplay 
between the innate immune system and commensal 
fungi that is responsible for maintaining the integrity of 
the mucosa. On the one hand, components of the innate 
immune system recognize the invading pathogens and 
limit the overgrowth of commensal fungi by intra- or 
extracellular killing (Romani 2011). On the other hand, 
contact with commensal microbes induces tolerance, that 
limits host damage caused by excessive inflammation 
(Romani 2011). Interleukin-10 (IL-10) is one of the most 
effective mediators of immune tolerance and it has been 
shown that patients with chronic candidal diseases often 
present high levels of this cytokine (Romani 2011). It has 
been shown that patients with OSCC have increased lev-
els of salivary IL-10 and high expression of this cytokine 
in tumor cells has been associated with poor prognosis 
(Chen et  al. 2013; Aziz et  al. 2015). Therefore, the anti-
inflammatory environment of neoplastic epithelium 
might support the proliferation of commensal yeasts by 
suppressing the activity of innate immune cells that are 
responsible for the limitation of microbial overgrowth. 
Using MALDI-TOF-MS analysis that represents a new 
and rapid method for the identification of yeasts in clini-
cal samples (Pinto et al. 2011; Bader et al. 2011), we found 
that in addition to higher fungal burdens, the spectrum 
of isolated yeast genera was wider in samples derived 
from OSCC patients compared to healthy controls. This 
finding further strengthens the notion that the altered 
microenvironment associated with tumorigenesis leads 
to the development of a more diverse oral microflora. 
In conclusion, our results reveal important differences 
in the oral fungal flora of OSCC patients compared to 
healthy individuals, although further research is needed 
to elucidate the etiologic relationship between Candida 
infection and carcinogenesis.
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